cdp ethanolamine has been researched along with Lipid Metabolism, Inborn Error in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakovic, M; Bonen, A; Fullerton, MD; Hakimuddin, F | 1 |
| Coleman, RA; Igal, RA | 1 |
2 other study(ies) available for cdp ethanolamine and Lipid Metabolism, Inborn Error
| Article | Year |
|---|---|
The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.
Topics: Animals; Cytidine Diphosphate; Diglycerides; Ethanolamines; Fatty Liver; Female; Gene Expression Regulation; Hypertriglyceridemia; Insulin Resistance; Lipid Metabolism, Inborn Errors; Male; Metabolic Syndrome; Mice; Mice, Knockout; Phosphatidylethanolamines; Phosphatidylserines; RNA Nucleotidyltransferases; Triglycerides | 2009 |
Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phospholipid metabolism.
Topics: Cells, Cultured; Choline; Cytidine Diphosphate; Cytidine Diphosphate Choline; Diglycerides; Ethanolamine; Ethanolamines; Fibroblasts; Glycerol; Homeostasis; Humans; Lipid Metabolism, Inborn Errors; Oleic Acid; Phosphatidylcholines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Sphingomyelins; Triglycerides | 1998 |